WGS: Piper Sandler Raises Target
Piper Sandler maintains overweight rating on GeneDx Holdings and raises price target to $63
Piper Sandler Maintains Overweight on GeneDx Holdings, Raises Price Target to $63
Piper Sandler maintains overweight rating on GeneDx Holdings and raises price target to $63
Piper Sandler Maintains Overweight on GeneDx Holdings, Raises Price Target to $63